SCHEMBL30944261

SCHEMBL30944261

CCOC(=O)c1ccc2c(-c3ccncc3)c(-c3ccc(F)cc3)nn2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 15/20 0.64
CSNK1A1 P48729 2/20 0.64
CSNK1D P48730 2/20 0.64
CSNK1E P49674 1/20 0.64
ALOX5 P09917 1/20 0.54
EGFR P00533 1/20 0.51
RAF1 P04049 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
ADORA2A P29274 1/20 0.51
ADORA2B P29275 1/20 0.51
ADORA1 P30542 1/20 0.51
GSK3B P49841 1/20 0.51
GCGR P47871 1/20 0.49
KDM4E B2RXH2 2/20 0.48
HPGD P15428 2/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30944233 0.85 MAPK14 (0.70) MAPK14CSNK1A1CSNK1DCSNK1EEGFR
SCHEMBL30944230 0.83 MAPK14 (0.72) MAPK14CSNK1A1CSNK1DCSNK1EALOX5
SCHEMBL5400284 0.82 MAPK14 (0.70) MAPK14CSNK1A1CSNK1DCSNK1EEGFR
SCHEMBL4865446 0.82 TGFBR1 (0.53) MAPK14CSNK1A1CSNK1DCSNK1EALOX5
SCHEMBL5391299 0.78 MAPK14 (1.00) MAPK14CSNK1A1CSNK1DCSNK1EEGFR
SCHEMBL5384440 0.78 MAPK14 (1.00) MAPK14CSNK1A1CSNK1DCSNK1EEGFR
SCHEMBL30944208 0.77 MAPK14 (0.70) MAPK14CSNK1A1CSNK1DCSNK1EEGFR
SCHEMBL5725033 0.76 MAPK8 (0.47) MAPK14CSNK1DKDM4EHPGDALDH1A1
SCHEMBL14592939 0.75 MAPK14 (0.49) MAPK14CSNK1A1CSNK1DCSNK1EEGFR
SCHEMBL5760751 0.73 MAPK14 (0.57) MAPK14CSNK1A1CSNK1DCSNK1EALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4638448-A1 CONJUGATES COMPRISING ANTIFUNGALS AND CASEIN KINASE (CK1) INHIBITORS AND METHODS OF USE THEREOF Bright Angel Therapeutics Inc. (CA) 2025-10-29 EP disclosed
WO-2024130408-A1 CONJUGATES COMPRISING ANTIFUNGALS AND CASEIN KINASE (CK1) INHIBITORS AND METHODS OF USE THEREOF BRIGHT ANGEL THERAPEUTICS INC. (CA) 2024-06-27 WO disclosed